Thrombectomy Devices Market Report: Trends, Forecast and Competitive Analysis to 2030

Thrombectomy Devices Trends and Forecast

The future of the global thrombectomy devices market looks promising with opportunities in the peripheral disease, coronary disease, and neural disease markets. The global thrombectomy devices market is expected to reach an estimated $2.0 billion by 2030 with a CAGR of 5.8% from 2024 to 2030. The major drivers for this market are the growing prevalence of cardiovascular disorders, the increasing number of healthcare facilities, and on-going technological advancements in thrombectomy devices.

• Lucintel forecasts that, within the technology category, mechanical thrombectomy is expected to witness the highest growth over the forecast period due to its increasing application to provide improved efficacy in the treatment of diseases.

• Within the application category, neural diseases will remain the largest segment due to the rising prevalence of neurological disorders and increasing government policies to spread awareness about neural diseases among the population.

• In terms of regions, APAC is expected to witness the highest growth over the forecast period due to the growing geriatric population and increasing government insurance coverage in the developing countries of the region. Gain valuable insights for your business decisions with our 150+ page report.

Emerging Trends in the Thrombectomy Devices Market

The market for thrombectomy devices is progressively and swiftly changing and developing with advancing trends that couldn’t have been imagined. Factors such as new technological innovations, new healthcare demands, and increased attention to patient outcomes propel these advancing trends. AI integration, miniaturization, and personalized medicine are some of the major trends affecting the growth of the market.

• AI Integration in Thrombectomy Devices: AI in invasive procedures: In order to perform better than traditional procedures, AI has been adopted for performing non-invasive surgery. AI algorithms assist in determining more accurately where the clot should be dissolved, which makes the procedures more productive and reduces the risks involved. As a result, such solutions positively influence patient outcomes, which is expected from the functionality of next-generation appliances.

• Miniaturization of Thrombectomy Devices: Due to device miniaturization, features of the basic vascular structure can be therapeutically approached via smaller thrombectomy systems that allow less traumatic procedural approaches, decrease recovery durations, and limit complications. Smaller devices are also designed for complex vasculature and can treat more patients. This trend is more notable in markets centered on minimally invasive surgery.

• Personalized Medicine and Thrombectomy: The concepts of personalized medicine have begun to affect the design of thrombectomy devices, with particular emphasis on modifying procedures according to individual variables. This strategy promotes increased therapeutic effectiveness and a reduced likelihood of undesirable effects, consistent with the development of medical devices that include personalization.

• Expansion of Outpatient Thrombectomy Procedures: The outpatient route for thrombus removal is geared toward the progress of devices and procedural techniques that lessen the necessity for hospital care. This trend resonates with the ambitions of healthcare systems seeking to reduce their expenses, as well as the patients’ priorities.

• Robotic-Assisted Thrombectomy Devices: There is an upward trend in the utilization of robotic-assisted thrombectomy devices, as their accuracy and control during procedures are enhanced. Minimizing human error and achieving good procedural results, especially in complicated cases, are additional advantages of these devices. Over time, more robotic procedures in thrombectomy will be embraced. These trends have emerged in the market for thrombectomy devices and have driven its modernization, enhancing therapeutic results for patients. The further development of these migratory trends goes, the more crucial they will be in the growth of the global turnover of the device market.

Recent Developments in the Thrombectomy Devices Market

Though still in its infancy, the thrombectomy devices market is developing at an unprecedented pace spurred by changes in technology, policies, and healthcare services. These developments work toward making thrombectomy procedures more effective, with relatively shorter recuperation periods and better results for patients. Important developments include the application of artificial intelligence, improvements in product design, and the licensing of new products. These changes are not only broadening the market but are also redefining standards in stroke treatment and vascular intervention, ensuring continued evolution in the thrombectomy devices market.

• AI-Enhanced Imaging: AI incorporation into image processing systems is enhancing clot detection during thrombectomy surgeries. This development has resulted in shorter operation durations and less risk, while also improving patients’ conditions, thereby impacting market growth and acceptance for AI devices.

• Next-Generation Device Approvals: New, more advanced thrombectomy devices with enhanced effectiveness and safety are being authorized for use by regulatory agencies. As a result, the implementation of sustainable devices is being hastened, creating a positive impact on the market.

• Robotic-Assisted Procedures: The adoption of robotic-assisted thrombectomy devices is growing in frequency, providing surgeons with improved operational techniques. This enhancement is lessening the chances of complications and securing better outcomes in difficult cases, furthering the uptake of robotic vascular systems.

• Cost-Effective Solutions: Cost-effective thrombectomy devices are helping drive an analgesic approach to treatment, especially in developing countries. Such solutions will enhance market expansion by broadening the treatable population and meeting market needs.

• Focus on Outpatient Care: Based thrombectomy devices are increasingly enabling outpatient procedures and decreasing the length of hospital stays. This trend is decreasing healthcare expenses, enhancing patients’ comfort, and promoting the use of thrombectomy devices in outpatient departments, thereby changing the competitive environment. Such critical dynamics are emerging to change the landscape of the thrombectomy devices market, instigating creativity and enhancing the provision of cutting-edge therapies. In light of these factors, such changes are projected to transform the treatment of stroke and vascular intervention globally.

Strategic Growth Opportunities for Thrombectomy Devices Market

The thrombectomy devices market is experiencing unprecedented growth due to technological innovation and the increasing occurrence of stroke. With the growing demand for efficiency and minimum invasiveness in the management of acute ischemic stroke, thrombus removal devices are becoming a staple. This analysis evaluates key market expansion opportunities and their possible influence on patients and their outcomes, as well as the market itself.

• Stent Retrievers Improvements: An increase in more effective and versatile stent retrievers is driving market growth. These devices enable efficient capture and removal of clots, ultimately increasing the acceptance of their usage.

• Expansion in Emerging Markets: Economic growth within developing countries and increased awareness of stroke provide thrombectomy device manufacturers with significant opportunities.

• Neuroimaging Technologies Adoption: The combination of thromboaspiration and other thrombectomy devices with advanced imaging techniques like CT angiography and MRI scans improves procedures by providing timely and effective treatments.

• Minimally Invasive Methods Development: The move toward conducting less invasive forms of thrombectomy procedures, such as endovascular techniques and small-sized devices, is spurring advancement in the market and enhancing the patient population.

• Targeted Treatment Approach: Efforts to improve treatment through the customization of procedures according to the characteristics of the clot and the severity of the stroke are being strategized. All these factors have contributed to the rapid growth of the thrombectomy devices market. By focusing on clinical gaps and available technology, manufacturers are bringing in changes and enhancing care.

Thrombectomy Devices Market Driver and Challenges

The thrombectomy devices market includes different technologies evolving from constant shifts in economics, including moves by governing agencies, economic factors, and engineering advancements. To navigate the market terrain efficiently, it is important to understand these drivers and challenges. The factors responsible for driving the thrombectomy devices market include:

• Technological Advancements: The market has been growing due to constant improvements in device designs, materials, and imaging technology. Devices such as self-expanding stents and better clot retrieval systems are increasing treatment effectiveness.

• Increasing Prevalence of Stroke: The growing global burden of stroke, particularly ischemic stroke, has been a significant driver for the thrombectomy devices market. With an aging population and increasing risk factors, there is a rising need for effective treatment methods.

• Improved Patient Outcomes: The use of thrombectomy devices has been shown to improve patient outcomes concerning mortality and disability rates. This success has also increased the market penetration of these devices.

• Reimbursement Policies: In both public and private practices, appropriate reimbursement policies play a crucial role in the market's development. Reasonable reimbursement for thrombectomy procedures normalizes patient access and promotes the market.

• Increasing Healthcare Spending: The growing expenditure on healthcare services and technologies, especially in developed countries, presents opportunities for device manufacturers, particularly for increased spending on thrombectomy devices. Healthcare providers are investing in higher technologies, leading to increased demand for interventional systems. Challenges in the thrombectomy devices market are:

• Regulatory Hurdles: Manufacturers of medical devices may struggle with the burden of regulatory requirements such as clinical trials, approval procedures, and reimbursement. Delays in seeking approvals can significantly impact business operations.

• High Costs: Healthcare practitioners and insurance companies may find the pricing associated with purchasable thrombectomy devices to be a bottleneck due to initial costs and ongoing maintenance expenses. Market development will depend on efforts to reduce costs and enhance competitiveness.

• Limited Access in Emerging Markets: Countries with developing economies may continue to show high demand for thrombectomy devices, but access may be limited due to economic challenges and inadequate healthcare systems. Meeting these challenges is critical for increasing market share. Technological advancements in thrombectomy devices, surging stroke prevalence, and better patient management have been boosting the market. However, obstacles like regulatory issues, high pricing, and market penetration challenges, especially in developing nations, pose significant problems. Effectively addressing these issues remains critical for market growth and the delivery of quality care services to stroke victims.

List of Thrombectomy Devices Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies thrombectomy devices companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the thrombectomy devices companies profiled in this report include-

• Stryker Corporation

• Boston Scientific

• Abbott Laboratories

• Koninklijke Philips N.V.

• Medtronic

• Penumbra

• Terumo Corporation

• Teleflex Incorporated

• AngioDynamics

• Johnson & Johnson

Thrombectomy Devices by Segment

The study includes a forecast for the global thrombectomy devices by technology, type, application, utility, and region.

Thrombectomy Devices Market by Technology [Analysis by Value from 2018 to 2030]:

• Mechanical Thrombectomy

• Aspiration Thrombectomy

• Rheolytic Thrombectomy

Thrombectomy Devices Market by Type [Analysis by Value from 2018 to 2030]:

• Automated Devices

• Manual Devices

Thrombectomy Devices Market by Application [Analysis by Value from 2018 to 2030]:

• Peripheral Diseases

• Coronary Disease

• Neural Diseases

Thrombectomy Devices Market by Utility [Analysis by Value from 2018 to 2030]:

• Reusable Devices

• Disposable Devices

Thrombectomy Devices Market by Region [Analysis by Value from 2018 to 2030]:

• North America

• Europe

• Asia Pacific

• The Rest of the World

Country Wise Outlook for the Thrombectomy Devices Market

The thrombectomy devices market has been broadening in scope due to improved healthcare delivery systems and the rise in cardiovascular diseases. Key markets such as the United States, China, Germany, India, and Japan are witnessing positive growth, driven by healthcare regulations, technological advancements, and an aging population.

• United States: There has been an increase in the use of high-end thrombectomy devices in the US due to supportive FDA approvals. Hospitals are deploying tools driven by AI to enhance the precision of procedures, which will help grow the market.

• China: Awareness and healthcare investments are promoting China’s thrombectomy market. Local companies are focusing on developing affordable devices, thereby improving the market’s competitiveness against foreign manufacturers by enhancing market access.

• Germany: Germany’s market is characterized by high research and development practices, including the manufacture of advanced thrombectomy devices. The demand for this approach is supported by a developed healthcare system and insurance framework.

• India: There is an upsurge in the usage of thrombectomy devices within the country, attributed to increasing health awareness and government efforts to reform stroke management. Enhanced healthcare facilities and affordable solutions are also driving growth.

• Japan: The growth in Japan can be explained by technological developments and the increase in the aging population. The adoption of robotic-assisted thrombectomy devices is also rising due to government healthcare reforms aimed at improving service quality.

Features of the Global Thrombectomy Devices Market

Market Size Estimates: Thrombectomy devices market size estimation in terms of value ($B). Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions. Segmentation Analysis: Thrombectomy devices market by various segments, such as by technology, type, application, utility and region in terms of($B). Regional Analysis: Thrombectomy devices market breakdown by North America, Europe, Asia Pacific, and Rest of the World. Growth Opportunities: Analysis of growth opportunities in different technologies, types, applications, utilities, and regions for the thrombectomy devices market. Strategic Analysis: This includes M&A, new product development, and competitive landscape of the thrombectomy devices market. Analysis of competitive intensity of the industry based on Porter’s Five Forces model.
If you are looking to expand your business in this market or adjacent markets, then contact us. We have done hundreds of strategic consulting projects in market entry, opportunity screening, due diligence, supply chain analysis, M & A, and more.

FAQ

Q.1 What is the thrombectomy devices market size? Answer: The global thrombectomy devices market is expected to reach an estimated $2.0 billion by 2030. Q.2 What is the growth forecast for thrombectomy devices market? Answer: The global thrombectomy devices market is expected to grow with a CAGR of 5.8% from 2024 to 2030. Q.3 What are the major drivers influencing the growth of the thrombectomy devices market? Answer: The major drivers for this market are the growing prevalence of cardiovascular disorders, the increasing number of healthcare facilities, and ongoing technological advancements in thrombectomy devices. Q4. What are the major segments for thrombectomy devices market? Answer: The future of the thrombectomy devices market looks promising with opportunities in the peripheral disease, coronary disease, and neural disease markets. Q5. Who are the key thrombectomy devices market companies? Answer: Some of the key thrombectomy devices companies are as follows:

• Stryker Corporation

• Boston Scientific

• Abbott Laboratories

• Koninklijke Philips N.V.

• Medtronic

• Penumbra

• Terumo Corporation

• Teleflex Incorporated

• AngioDynamics

• Johnson & Johnson Q6. Which thrombectomy devices market segment will be the largest in future? Answer: Lucintel forecasts that mechanical thrombectomy is expected to witness the highest growth over the forecast period due to its increasing application to provide improved efficacy in the treatment of diseases. Q7. In thrombectomy devices market, which region is expected to be the largest in next 5 years? Answer: APAC is expected to witness the highest growth over the forecast period due to the growing geriatric population and increasing government insurance coverage in the developing countries of the region. Q.8 Do we receive customization in this report? Answer: Yes, Lucintel provides 10% customization without any additional cost.